Mast-cell stabilizers prevent the release of chemical mediators of inflammation from the mast cells. These are effective for all eye allergies. The first of this class of drug was cromolyn sodium (Crolom or Opticrom), which is available OTC. This topical medicine has been effective for treating mild cases of vernal keratoconjunctivitis and probably mild allergic rhinoconjunctivitis and has no significant side effects. It does have a slow onset of action. The newer agent, lodoxamide (Alomide), is 2,500 times more potent than Crolom and has a faster onset of action. This prescription medicine may be used in children older than 2 years of age and has minimal side effects. One disadvantage is the need to use the drops four times a day, and long-term use is necessary to prevent symptoms.